Il y a eu 50 transactions d'initiés récentes enregistrées pour Aprea Therapeutics, Inc. (APRE), dont 47 achats et 2 ventes. Le total des achats d'initiés s'élève à $933.51K et le total des ventes d'initiés à $47.13K.
Les initiés notables ayant une activité récente comprennent Peters Richard, Hamill John P., Gilad Oren. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — APRE
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-31 |
Peters Richard |
Director |
Achat Informatif |
123,915 |
$0.68 |
$84.63K |
123,915 |
| 2026-03-31 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Achat Informatif |
30,978 |
$0.68 |
$21.16K |
30,978 |
| 2026-03-12 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Attribution de RSU |
40,380 |
$0.77 |
$30.89K |
40,380 |
| 2026-03-12 |
Gilad Oren |
President/ceo |
Attribution de RSU |
80,700 |
$0.77 |
$61.74K |
80,700 |
| 2026-01-30 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Achat Informatif |
5,700 |
$0.77 |
$4.36K |
5,700 |
| 2026-01-30 |
Gilad Oren |
President/ceo |
Achat Informatif |
28,100 |
$0.77 |
$21.5K |
28,100 |
| 2025-12-10 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Achat Informatif |
5,000 |
$1.04 |
$5.2K |
5,000 |
| 2025-12-10 |
Duey Marc |
Director |
Achat Informatif |
21,459 |
$1.04 |
$22.32K |
21,459 |
| 2025-12-10 |
Gilad Oren |
President/ceo |
Achat Informatif |
21,459 |
$0.00 |
$2.15 |
21,459 |
| 2025-06-05 |
Henneman John B Iii |
Director |
Attribution de RSU |
4,185 |
$1.81 |
$7.57K |
4,185 |
| 2025-06-05 |
Bizzari Jean-pierre |
Director |
Attribution de RSU |
1,045 |
- |
- |
1,045 |
| 2025-06-05 |
Peters Richard |
Director |
Attribution de RSU |
1,045 |
- |
- |
3,119 |
| 2025-06-05 |
Grissinger Michael |
Director |
Attribution de RSU |
1,045 |
- |
- |
2,889 |
| 2025-06-05 |
Seizinger Bernd R. |
Director |
Attribution de RSU |
4,185 |
$1.81 |
$7.57K |
4,185 |
| 2025-06-05 |
Gruia Gabriela |
Director |
Attribution de RSU |
1,045 |
- |
- |
1,045 |
| 2025-06-05 |
Duey Marc |
Director |
Attribution de RSU |
4,185 |
$1.81 |
$7.57K |
4,185 |
| 2025-06-05 |
Pamukcu Rifat |
Director |
Attribution de RSU |
4,185 |
$1.81 |
$7.57K |
4,185 |
| 2025-04-03 |
Gilad Oren |
President/ceo |
Achat Informatif |
3,003 |
$1.87 |
$5.62K |
343,123 |
| 2025-03-27 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Attribution de RSU |
13,460 |
$2.20 |
$29.61K |
13,460 |
| 2025-03-27 |
Gilad Oren |
President/ceo |
Attribution de RSU |
26,900 |
$2.20 |
$59.18K |
26,900 |
| 2024-10-23 |
Gilad Oren |
President/ceo |
Achat Informatif |
500 |
$3.92 |
$1.96K |
333,395 |
| 2024-10-18 |
Duey Marc |
Director |
Vente Informative |
6,462 |
$4.58 |
$29.58K |
233,651 |
| 2024-10-16 |
Duey Marc |
Director |
Achat Informatif |
30,000 |
$4.39 |
$131.7K |
240,113 |
| 2024-10-15 |
Gilad Oren |
President/ceo |
Achat Informatif |
250 |
$2.90 |
$725.00 |
332,895 |
| 2024-10-14 |
Gilad Oren |
President/ceo |
Achat Informatif |
1,000 |
$2.59 |
$2.59K |
332,645 |
| 2024-10-14 |
Duey Marc |
Director |
Achat Informatif |
190 |
$2.58 |
$490.20 |
210,113 |
| 2024-10-11 |
Seizinger Bernd R. |
Director |
Achat Informatif |
10,000 |
$2.68 |
$26.8K |
44,730 |
| 2024-10-11 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Achat Informatif |
50 |
$2.46 |
$123.19 |
19,368 |
| 2024-10-10 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Achat Informatif |
450 |
$2.61 |
$1.17K |
19,318 |
| 2024-10-10 |
Gilad Oren |
President/ceo |
Achat Informatif |
150 |
$2.54 |
$381.00 |
331,645 |
| 2024-06-20 |
Henneman John B Iii |
Director |
Attribution de RSU |
4,185 |
$4.07 |
$17.03K |
4,185 |
| 2024-06-20 |
Peters Richard |
Director |
Attribution de RSU |
1,045 |
- |
- |
2,074 |
| 2024-06-20 |
Grissinger Michael |
Director |
Attribution de RSU |
1,045 |
- |
- |
1,844 |
| 2024-06-20 |
Seizinger Bernd R. |
Director |
Attribution de RSU |
4,185 |
$4.07 |
$17.03K |
4,185 |
| 2024-06-20 |
Duey Marc |
Director |
Attribution de RSU |
4,185 |
$4.07 |
$17.03K |
4,185 |
| 2024-06-20 |
Pamukcu Rifat |
Director |
Attribution de RSU |
4,185 |
$4.07 |
$17.03K |
4,185 |
| 2024-05-01 |
Mirza Nadeem Q. |
Chief Medical Officer |
Cession |
2,250 |
$7.80 |
$17.55K |
- |
| 2024-05-01 |
Mirza Nadeem Q. |
Chief Medical Officer |
Attribution de RSU |
6,730 |
- |
- |
6,730 |
| 2024-03-28 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Attribution de RSU |
13,460 |
$6.69 |
$90.05K |
13,460 |
| 2024-03-28 |
Gilad Oren |
President, CEO |
Attribution de RSU |
26,900 |
$6.69 |
$179.96K |
26,900 |
| 2024-03-13 |
Henneman John B Iii |
Director |
Achat Informatif |
3,430 |
- |
- |
3,430 |
| 2024-03-13 |
Hamill John P. |
Srvp/cfo/prin Fin & Acct Ofcr |
Achat Informatif |
505 |
- |
- |
505 |
| 2024-03-13 |
Seizinger Bernd R. |
Director |
Achat Informatif |
3,430 |
- |
- |
3,430 |
| 2024-03-13 |
Gilad Oren |
President, CEO |
Achat Informatif |
1,000 |
- |
- |
1,000 |
| 2023-08-23 |
Henneman John B Iii |
Director |
Attribution de RSU |
500 |
- |
- |
1,279 |
| 2023-08-23 |
Bizzari Jean-pierre |
Director |
Inconnu |
- |
- |
- |
- |
| 2023-08-23 |
Bizzari Jean-pierre |
Director |
Attribution de RSU |
12,500 |
$3.65 |
$45.63K |
12,500 |
| 2023-08-23 |
Peters Richard |
Director |
Attribution de RSU |
500 |
- |
- |
1,029 |
| 2023-08-23 |
Grissinger Michael |
Director |
Attribution de RSU |
500 |
- |
- |
799 |
| 2023-08-23 |
Seizinger Bernd R. |
Director |
Attribution de RSU |
2,000 |
$3.65 |
$7.3K |
2,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
